Open-label, Flexible-dose Study of Vortioxetine in Patients With Depression in India

NCT04288895 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

400

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder

Interventions

DRUG: Vortioxetine

Sponsor

H. Lundbeck A/S